A Prospective Registry Study of Patients With Hypertension

Part of paid clinical trials in Palo Alto, California.

Sponsor
Vivek Bhalla
Study ID
NCT07579260
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

An estimated 120 million people have high blood pressure (hypertension) in the US, of which approximately 10% have resistant hypertension. This study aims to enroll patients who continue to have hypertension while being treated with at least two medications. The study will follow patients for approximately 3 months and collect real-world information on changes in their health to identify an ideal patient profile that would benefit from 4th-line antihypertensive therapies, including, but not limited to, FDA-approved aprocitentan.

Key Dates

Start date
Jul 1, 2026
Status verified
May 2026
Primary completion
Apr 1, 2027
Completion
Apr 1, 2027

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Change from baseline to Month 3 in mean sitting office SBP [ Time Frame: 90 days ]

Locations (2)

FacilityCityStateZIPSite coordinators
Stanford University Hypertension CenterPalo AltoCalifornia94304
Joel Nicholus, MA
[email protected]
650-947-7025
Duke University HospitalDurhamNorth Carolina27710
Krista Camuglia, BSN
[email protected]
919-862-5967

Find similar trials in Palo Alto, CA

By condition
Hypertension (high blood pressure)
By specialty
CardiologyHeart disease
By research site
Stanford University Hypertension Center· Palo Alto, CADuke University Hospital· Durham, NC

Related Studies